5
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Transformation-sensitive Cells in G2/M-phase are Not Promoted by TPA Following 137Cs γ-rays

, , , &
Pages 727-730 | Received 16 Jun 1993, Accepted 16 Aug 1993, Published online: 03 Jul 2009

References

  • Cao J., Wells R.L., Elkind M.M. Enhanced sensitivity to neoplastic transformation by 137Cs γ-rays of cells in the G2/M-phase age interval. International Journal of Radiation Biology 1992; 62: 191–199
  • Cao J., Wells R.L., Elkind M.M. Neoplastic transformation of C3H mouse embryo cells, 10T1/2: cell-cycle dependence for 50KV X-rays and UV-B light. International Journal of Radiation Biology 1993; 64: 83–92
  • Castagna M., Takai Y., Kaibuchi K., Sano K., Nishizuka Y. Direct activation of calcium activated, phospholipid-dependent protein kinase by tumorpromoting phorbol esters. Journal of Biological Chemistry 1982; 257: 7847–7851
  • DiPaolo J.A., Evans C.H., Popescu N.C., Doniger J.N. Regulation of mammalian cell transformation. Carcinogenesis, 7, E. Hecker. Raven Press, NY 1982; 273–276, In
  • Elkind M.M. Enchanced neoplastic transformation due to protracted exposures of fission-spectrum neutrons: biophysical model. International Journal of Radiation Biology 1991a; 59: 1467–1475
  • Elkind M.M. Physical, biophysical, and cellbiological factors that can contribute to enhanced neoplastic transformation by fission-spectrum neutrons. Radiation Research 1991b; 128: S47–S52
  • Elkind M.M. Enhanced neoplastic transformation by protracted exposures of high-LET radiations: a cellkinetic model based upon a G2/M-phase window of sensitivity. Low Dose Irradiation and Biological Defense Mechanisms, T. Sugahara, L.A. Sagan, T. Aoyama. Elsevier, Amsterdam 1992; 29–35, In
  • Han A., Elkind M.M. Enhanced transformation of mouse 10T1/2 cells by 12-O-tetradecanoyl phorbol-13-acetate following exposure to X-rays or to fissionspectrum neutrons. Cancer Research 1982; 42: 477–483
  • Han A., Hill C.K., Elkind M.M. Repair of cell killing and neoplastic transformation at reduced doserates of 60Co γ-rays. Cancer Research 1980; 40: 3328–3332
  • Hill C.K., Buonaguro F.M., Myers C.P., Han A., Elkind M.M. Fission-spectrum neutrons at reduced dose-rates enhance neoplastic transformation. Nature (London) 1982; 298: 67–69
  • Hill C.K., Han A., Elkind M.M. Fissionspectrum neutrons at a low dose-rate enhance neoplastic transformation in the linear, low-dose region (0–10 Gy). International Journal of Radiation Biology 1984; 46: 11–16
  • Hill C.K., Han A., Elkind M.M. Promotion, dose-rate, and repair processes in radiation induced neoplastic transformation. Radiation Research 1987; 109: 347–351
  • Hill C.K., Zhu L. Energy and dose-rate dependence of neoplastic transformation and mutation in mammalian cells by fast neutrons. Radiation Research 1991; 128: S53–S59
  • Kennedy A.R., Mondal S., Heidelberger C., Little J.B. Enhancement of X-ray transformation 12-O-tetradecanoyl phorbol-13-acetate in a cloned line of C3H mouse embryo cells. Cancer Research 1978; 38: 439–443
  • Kennedy A.R., Murphy G., Little J.B. The effect of time and duration of exposure to 12-O-tetradecanoyl phorbol-13-acetate on X-ray transformation of C3H 10T1/2 cells. Cancer Research 1980; 40: 1915–1920
  • Miller R.C., Randers-Pherson G., Heiber L., Marino S.A., Richards M., Hall E.J. The inverse dose-rate effect for oncogenic transformation by charged particles is dependent on linear energy transfer. Radiation Research 1993; 133: 360–364
  • Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature (London) 1988; 334: 661–665

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.